The Climate Biotech Podcast

On this episode of The Climate Biotech Podcast, we are joined by Henry Lee, CEO of Cultivarium, a Focused Research Organization (FRO) that accelerates the engineering of non-model organisms. 
Henry came to biotechnology through electrical engineering, after a chance opportunity to dissect crayfish neurons inspired a passion for using engineering to understand biology while using biology to engineer. During his postdoc in George Church's lab, he pursued what he calls "bucket list science." For one of his projects, he developed new methods to culture and engineer the bacterium Vibrio natriegens, which is one of the fastest-growing organisms ever described and grows roughly twice as quickly as E. coli. That work shaped Cultivarium's approach to the broader problem of non-model organisms. 
Henry believes that the mental model of applied biology has traditionally been far too one-to-one, focusing on a single organism for a single application: “If you’re interested in plastic degradation, well have you heard of this one microbe that does plastic degradation?” In reality, most useful capabilities are shared amongst many organisms, and we would ideally draw on that full diversity to develop solutions. Cultivarium is developing tools to make it easier to work with diverse organisms to find what works best for a particular goal. 
Listen to learn how Cultivarium is changing the way researchers approach engineering non-model organisms.
Send us Fan Mail

On this episode of The Climate Biotech Podcast, Paul Reginato is joined by Kiara Reyes Gamas, environmental synthetic biologist and non-resident postdoctoral scholar at Rice University's Baker Institute. Alongside her bench science, she has consistently engaged with the social and governance dimensions of synthetic biology, which shapes how she thinks about engineering microbes for environmental release.
Much of Kiara’s work has focused on horizontal gene transfer, the process by which microbes naturally swap DNA throughout the environment. It is how antibiotic resistance spreads, and it is one of the central reasons regulators worry about releasing engineered microbes. The problem is that we have very poor measurements of how often it actually happens in natural settings in complex communities, or which organisms participate. 
Kiara’s research also suggests that the field's default toward biocontainment may be missing the point for environmental applications. A microbe engineered to clean up an oil spill has to interact with the environment to do its job. The more useful questions are about which genes are safe to introduce, how engineered organisms behave under selective pressure in microbial communties, how to integrate human communities into the governance of these technologies, and whether the regulatory scrutiny applied to recombinant DNA should extend to any non-native microbe being released. 
Listen to learn how RNA-based barcoding extends the reach of horizontal gene transfer measurements across microbial species, what ecology has to teach synthetic biologists about environmental release, and why Kiara argues that community co-design is an engineering requirement rather than a regulatory checkbox. 

Send us Fan Mail

On this episode of The Climate Biotech Podcast, Paul is joined by Eli Hornstein, founder and CEO of Elysia Bio, a company engineering feed crops to address methane emissions from livestock. Eli came to plant biotech through an unlikely path: undergraduate degrees in ecology and linguistics, conservation fieldwork across East Africa and South America, and a Fulbright Fellowship in Mongolia before a PhD in plant genetic engineering at NC State. That ecological background shapes how Eli thinks about intervention points in agriculture.
One of Eli’s core insights is that plant biotech has spent decades optimizing plants for the plant's sake while largely ignoring that those plants are actually for feeding animals. Enteric methane from ruminants is the single largest source of methane on Earth – larger than oil and gas – and most of those animals are on pasture with few practical options for emissions reduction. 
Elysia's first trait encodes bromoform, a methane-inhibiting compound from red seaweed, directly into corn so farmers don't need to change feeding practices. The company has since expanded into pasture grasses and other crops to reach ruminants outside commodity feed systems. Their most ambitious project, the PlaMMO Project, engineers plants to express methane monooxygenase (MMO), the enzyme methanotrophs use to oxidize methane, potentially enabling crops to pull methane directly from the atmosphere. Elysia is currently running analytical chemistry on their first MMO-expressing plant candidates.
Listen to learn about the community of researchers working to de-risk heterologous MMO expression, why plant synthetic biology is underrated relative to microbial systems, and why Eli thinks ecological thinking is one of the most undervalued skills in biotech. Plus, learn how a photosynthesizing sea slug inspired a company name.
Send us Fan Mail

In Dan Goodwin’s final episode as host, The Climate Biotech Podcast reflects on over 30 episodes of conversations with scientists, entrepreneurs, and builders at the frontier of climate biotechnology, and marks the official handover of the podcast to Homeworld Collective's new Executive Director and co-founder, Paul Reginato.
Dan and Paul trace their partnership back to MIT, where they were both developing first-of-kind spatial genomics technologies in Ed Boyden and George Church's labs. What started as a shared drive to work on climate change grew into organic community building, and eventually into Homeworld Collective, an organization designed to connect climate biotech practitioners with high-leverage problems, collaborators, and funding.
The episode distills wisdom from the podcast's guests so far. When asked what shaped them as thinkers, guests overwhelmingly cited science fiction and art over technical papers. On mentor advice, the theme was self-advocacy: pick hard problems, learn to communicate your work, and trust your own intuition. And when asked where a magic wand of climate biotech should point, answers ranged from better field measurements for methane to the largely untapped interface between geology and biology.
At the end of the episode, Paul shares his vision for Homeworld's phase two: refinement and scaling of Homeworld’s methods through more community convenings, a new ambassador program, faster production of problem statements, and more focused grantmaking designed to nucleate productive research communities in underserved, high-impact problem spaces. Dan reflects on his framework for choosing what comes next and highlights the underappreciated connection between environmental pollutants and the 70-80% of human disease that remains sporadic and unexplained.
Listen for the best career advice for early-career scientists, like "nail your projects, don't pick your track,” what a tadpole losing its tail teaches us about growth, and why building friendships across disciplinary boundaries can unlock your own potential to impact some of the most important problems of our time. 

Send us Fan Mail

On the most recent episode of the Climate Biotech Podcast, we are joined by Ginger Krieg Dosier, an architect-turned-biotech entrepreneur who created biocement at Biomason and is now building BIOME Consortia to accelerate biology's transition from thousands to billions of applications. Ginger's journey from NASA kid in Alabama to founding one of climate biotech's earliest companies reveals how architectural thinking translates surprisingly well to biological innovation. 
Ginger’s approach at Biomasontackled concrete, the second most consumed substance on Earth after water. By using microbes to precipitate calcium carbonate at ambient temperature instead of firing kilns at 1500°C, they cut both emissions and energy usage dramatically. 
The pivot to BIOME emerged from a startling statistic: with an estimated one trillion microbial species on Earth and only 0.001% discovered, Ginger saw that the strain bank they'd built for biocement applications represented something far bigger. Today, fewer than 800 strains power all commercial applications - she believes we need billions by 2050.
BIOME’s two flagship initiatives address this gap. Atlas creates a digital microbial commons focused on access and interpretability, gamifying discovery and translation to engage more tinkerers. Arc tackles preservation, particularly of threatened environments like glaciers that lose tens of quadrillions of microbes to sea annually, while moving beyond minus-80 storage limitations.
Listen to learn why consortia-based biology may solve the scaling economics that sank many biomanufacturing companies, how visualization of the invisible microbiome could transform public engagement, and why the "age of complexity" might finally deliver on the 1999 prediction that the 21st century would be biology's era.
Send us Fan Mail